Top Science Longreads of 2013
By Ed Yong,
National Geographic
| 12. 23. 2013
I’m really optimistic about the future for long, deep, rich science reporting. There are more places that are publishing it, more ways of finding it, and a seemingly huge cadre of people who are writing it well. So without further ado, here’s a list of my top pieces of the year. It has blossomed to 15 from last year’s 12 because I was gripped by indecision and they’re all so good. In no particular order:
1)
Bones of Contention,
by Paige Williams for the New Yorker. The curious case of USA v. One Tyrannosaurus Bataar Skeleton frames this exquisitely crafted tale about a Florida man’s trade in Mongolian dinosaurs, and the amazing world of fossils, auctions, and private collectors.
“He sold sloth claws, elephant jaws, wolf molars, dinosaur ribs—a wide range of anatomical fragments that went, mostly, for between ten and fifty dollars. Increasingly, Florida Fossils got into triple digits, especially when Prokopi started selling dinosaur parts. In the fall of 2011, he sold two Mongolian oviraptor nests for more than three hundred and fifty dollars each, a...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...